Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer

doi:10.3748/wjg.v20.i42.15852

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5477)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

323

WORD

302

HTML

2692

Figures (1-4)

159

Tables (1-3)

155

Sum=3631

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

833

Download

1013

Sum=1846

Nov 14, 2014 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Clinical Trial

World J Gastroenterol. Nov 14, 2014; 20(42): 15852-15859
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15852

Full Size Figure Download Figure

Figure 3 Body weight changes in the first 3 d after surgery in two groups. Data are mean ± SD. POD: Postoperative day; R group: Restricted fluid therapy group; S group: Standard fluid therapy group. ^bP < 0.01 R group vs S group.

Citation: Jie HY, Ye JL, Zhou HH, Li YX. Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer. World J Gastroenterol 2014; 20(42): 15852-15859
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15852.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15852